# A Bioequivalence Study to Compare the Pharmacokinetics of Two Formulations of Siklos® in Healthy Volunteers

> **NCT05025072** · PHASE1 · COMPLETED · sponsor: **Theravia** · enrollment: 28 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Hydroxycarbamide dispersible tablets
- **DRUG:** Hydroxycarbamide film-coated tablet

## Key facts

- **NCT ID:** NCT05025072
- **Lead sponsor:** Theravia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-22
- **Primary completion:** 2021-09-29
- **Final completion:** 2021-09-29
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-10-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05025072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05025072, "A Bioequivalence Study to Compare the Pharmacokinetics of Two Formulations of Siklos® in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05025072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*